Wordt geladen...
Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology
Cancer immunotherapy using antigen-specific T cells has broad therapeutic potential. Chimeric antigen receptors and bispecific antibodies can redirect T cells to kill tumors without human leukocyte antigens (HLA) restriction. Key determinants of clinical potential include the choice of target antige...
Bewaard in:
| Gepubliceerd in: | Pediatr Blood Cancer |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976492/ https://ncbi.nlm.nih.gov/pubmed/25832831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25513 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|